U3 RNP (Fibrillarin) Antibodies
Fibrillarin is a nucleolar protein essential in pre-ribosomal RNA (rRNA) processing. As a methyltransferase, it catalyzes 2'-O-methylation of specific nucleotides on pre-rRNA, a crucial step for proper ribosome assembly and protein synthesis. Defects in fibrillarin, caused either by mutations or autoantibody interference, impair ribosomal biogenesis and cellular homeostasis.
Anti-fibrillarin (U3 RNP) autoantibodies are highly specific biomarkers for systemic sclerosis, particularly the diffuse subtype, and are associated with more severe disease including pulmonary hypertension, cardiac involvement, and gastrointestinal dysmotility. In CREST syndrome, approximately 80% of patients demonstrate anti-fibrillarin positivity. Clinical symptoms include calcium deposits in skin and tissues, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia.
- As an aid in the diagnosis of CREST syndrome and systemic sclerosis
- Supports differentiation from other connective tissue disorders when combined with ANA, Scl-70, and centromere antibodies
Positive in:
- CREST syndrome (particularly diffuse cutaneous subtype)
- Systemic sclerosis
Negative
Serum, SST tube.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 30 days
- Rheumatology (Oxford). 2001 Oct;40(10):1157-62. [PMID: 11600746]
- Curr Opin Rheumatol. 2004 Nov;16(6):723-32. [PMID: 15577611]
- Int J Mol Med. 2018 Mar;41(3):1213-1223. [PMID: 29286095]
- Mol Biol Cell. 1997 Jun;8(6):1051-61. [PMID: 9201715]
- Biochemistry (Mosc). 2016 Sep;81(9):941-50. [PMID: 27682166]